Clicky

Biogen Idec Inc.(BIIB) News

Date Title
Jul 30 New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 30 Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 30 Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
Jul 30 Biogen Earnings: What To Look For From BIIB
Jul 28 Biotech stocks dip as Trump administration mulls patent fee overhaul
Jul 28 Biogen Gears Up to Report Q2 Earnings: Here's What to Expect
Jul 28 BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
Jul 25 ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
Jul 23 Amyotrophic Lateral Sclerosis (ALS) Market Forecast Report 2025-2034 | Advancements in Therapeutics and Approved Medications Such as Riluzole, Edaravone, and Nuedexta Drive Growth
Jul 22 Biogen to invest further $2bn in North Carolina’s Research Triangle Park
Jul 21 Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
Jul 21 Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
Jul 21 Biogen (BIIB) Stock Trades Down, Here Is Why
Jul 21 Biogen beefs up North Carolina manufacturing ahead of potential Trump tariff
Jul 21 S&P 500, Nasdaq Scale New Highs in Broad-Based Rally
Jul 21 Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
Jul 21 Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm
Jul 21 Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
Jul 18 Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
Jul 18 Here's What to Expect From Biogen's Next Earnings Report